Literature DB >> 8426364

Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.

M L Nelson1, B H Park, J S Andrews, V A Georgian, R C Thomas, S B Levy.   

Abstract

A series of 13-(alkylthio) and 13-(arylthio) derivatives of 5-hydroxy-6-deoxytetracycline (tetracycline, Tc) were synthesized and compared to the clinically used antibiotics tetracycline, methacycline, and minocycline for their ability to inhibit tetracycline efflux in an everted membrane vesicle assay of bacterial resistance to tetracyclines. The assay screened for the ability of tetracycline analogues to inhibit [3H]tetracycline uptake into everted membrane vesicles, thereby evaluating the molecular prerequisites for inhibition of an efflux-dependent resistant bacterial system. Thiol adducts attached at the exocyclic C13 carbon of methacycline led to an increase in inhibitor potency as compared to the reference antibiotics. The most potent inhibitors of [3H]tetracycline uptake into everted vesicles among these analogues, particularly members of the alkyl series, revealed important structure-activity relationships between inhibitor potency, steric parameters, and lipophilicity at the C13 sulfur position.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426364     DOI: 10.1021/jm00055a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

Review 1.  Multidrug evolutionary strategies to reverse antibiotic resistance.

Authors:  Michael Baym; Laura K Stone; Roy Kishony
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

2.  Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein.

Authors:  M L Nelson; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

3.  The purified Bacillus subtilis tetracycline efflux protein TetA(L) reconstitutes both tetracycline-cobalt/H+ and Na+(K+)/H+ exchange.

Authors:  J Cheng; D B Hicks; T A Krulwich
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

5.  Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.

Authors:  O Lomovskaya; M S Warren; A Lee; J Galazzo; R Fronko; M Lee; J Blais; D Cho; S Chamberland; T Renau; R Leger; S Hecker; W Watkins; K Hoshino; H Ishida; V J Lee
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 6.  Tetracyclines-An Important Therapeutic Tool for Dermatologists.

Authors:  Malgorzata Orylska-Ratynska; Waldemar Placek; Agnieszka Owczarczyk-Saczonek
Journal:  Int J Environ Res Public Health       Date:  2022-06-13       Impact factor: 4.614

7.  The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria.

Authors:  J Barrett Deris; Minsu Kim; Zhongge Zhang; Hiroyuki Okano; Rutger Hermsen; Alexander Groisman; Terence Hwa
Journal:  Science       Date:  2013-11-29       Impact factor: 47.728

Review 8.  Biochemistry of bacterial multidrug efflux pumps.

Authors:  Sanath Kumar; Manuel F Varela
Journal:  Int J Mol Sci       Date:  2012-04-10       Impact factor: 6.208

9.  Brown and Red Seaweeds Serve as Potential Efflux Pump Inhibitors for Drug-Resistant Escherichia coli.

Authors:  Wen-Jung Lu; Hsuan-Ju Lin; Pang-Hung Hsu; Margaret Lai; Jen-Yu Chiu; Hong-Ting Victor Lin
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-01       Impact factor: 2.629

10.  Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens.

Authors:  Renee M Fleeman; Ginamarie Debevec; Kirsten Antonen; Jessie L Adams; Radleigh G Santos; Gregory S Welmaker; Richard A Houghten; Marc A Giulianotti; Lindsey N Shaw
Journal:  Front Microbiol       Date:  2018-06-14       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.